JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B1414 Azelnidipine

Summary: L-type calcium channel blocker;antihypertensive

≥27.15 mg/mL
B1490 Quetiapine Fumarate
1 Citation

Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors

Summary: Dopamine receptor antagonist

insoluble in H2O; insoluble in EtOH; ≥11.03 mg/mL
B1064 L-(-)-α-Methyldopa (hydrate)

Summary: Alpha-adrenergic agonist

insoluble in EtOH; insoluble in H2O; ≥4.74 mg/mL
B1947 Gemfibrozil

Summary: PPARα activator

≥10.15 mg/mL
B1555 Betahistine 2HCl

Summary: Histamine H3 receptor inhibitor

≥10.46 mg/mL
B1508 Ethynodiol diacetate

Summary: Progestogen receptor agonist

insoluble in H2O; ≥19.2 mg/mL
B6603 AM 281
3 Citation

Summary: CB1 antagonist

insoluble in H2O; insoluble in EtOH; ≥1.86 mg/mL
B6642 DMPQ dihydrochloride

Summary: PDGFRβ inhibitor

Soluble in H2O
B6647 Cyclopiazonic acid

Summary: sarcoplasmic reticulum Ca2+-ATPase inhibitor

Soluble in DMSO
B6964 Ro 0437626

Summary: P2X1 purinergic receptor antagonist

<52.57 mg/mL